Papers - YONEYAMA Tohru
-
Risk-stratified surveillance protocol improves cost-effectiveness after radical nephroureterectomy in patients with upper tract urothelial carcinoma.
Masaki Momota, Shingo Hatakeyama, Hayato Yamamoto, Hiromichi Iwamura, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Ikuya Iwabuchi, Masaru Ogasawara, Toshiaki Kawaguchi, Chikara Ohyama
Oncotarget 9 ( 33 ) 23047 - 23057 2018.5
-
Risk-stratified surveillance protocol improves cost-effectiveness after radical nephroureterectomy in patients with upper tract urothelial carcinoma.
Masaki Momota, Shingo Hatakeyama, Hayato Yamamoto, Hiromichi Iwamura, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Ikuya Iwabuchi, Masaru Ogasawara, Toshiaki Kawaguchi, Chikara Ohyama
Oncotarget 9 ( 33 ) 23047 - 23057 2018.5
-
Clinical implication of a quantitative frailty assessment tool for prognosis in patients with urological cancers.
Osamu Soma, Shingo Hatakeyama, Teppei Okamoto, Naoki Fujita, Teppei Matsumoto, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Shigeyuki Nakaji, Chikara Ohyama
Oncotarget 9 ( 25 ) 17396 - 17405 2018.4
-
Clinical implication of a quantitative frailty assessment tool for prognosis in patients with urological cancers.
Osamu Soma, Shingo Hatakeyama, Teppei Okamoto, Naoki Fujita, Teppei Matsumoto, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Shigeyuki Nakaji, Chikara Ohyama
Oncotarget 9 ( 25 ) 17396 - 17405 2018.4
-
Impact of bacillus Calmette–Guérin therapy of upper urinary tract carcinoma in situ: comparison of oncological outcomes with radical nephroureterectomy
Hirotaka Horiguchi, Takahiro Yoneyama, Shingo Hatakeyama, Noriko Tokui, Tendo Sato, Naoki Fujita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Kazuaki Yoshikawa, Satoshi Narita, Toshiaki Kawaguchi, Chikara Ohyama
Medical Oncology 35 ( 4 ) 41 2018.4
-
The Impact of Preoperative Severe Renal Insufficiency on Poor Postsurgical Oncological Prognosis in Patients with Urothelial Carcinoma.
Masaki Momota, Shingo Hatakeyama, Noriko Tokui, Tendo Sato, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Satoshi Narita, Toshiaki Kawaguchi, Chikara Ohyama
European urology focus 2018.3
-
Oncologic outcomes for open and laparoscopic radical nephroureterectomy in patients with upper tract urothelial carcinoma.
Koichi Kido, Shingo Hatakeyama, Naoki Fujita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Ikuya Iwabuchi, Masaru Ogasawara, Toshiaki Kawaguchi, Chikara Ohyama
International journal of clinical oncology 2018.2
-
Oncologic outcomes for open and laparoscopic radical nephroureterectomy in patients with upper tract urothelial carcinoma
Koichi Kido, Shingo Hatakeyama, Naoki Fujita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Ikuya Iwabuchi, Masaru Ogasawara, Toshiaki Kawaguchi, Chikara Ohyama
International Journal of Clinical Oncology 23 ( 4 ) 1 - 8 2018.2
-
Detecting asymptomatic recurrence after radical nephroureterectomy contributes to better prognosis in patients with upper urinary tract urothelial carcinoma.
Hirotaka Horiguchi, Shingo Hatakeyama, Go Anan, Yuka Kubota, Hirotake Kodama, Masaki Momota, Koichi Kido, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Makoto Sato, Chikara Ohyama
Oncotarget 9 ( 9 ) 8746 - 8755 2018.2
-
Presurgical axitinib therapy increases fibrotic reactions within tumor thrombus in renal cell carcinoma with thrombus extending to the inferior vena cava
Yoshimi Tanaka, Shingo Hatakeyama, Shogo Hosogoe, Toshikazu Tanaka, Itsuto Hamano, Ayumu Kusaka, Hiromich Iwamura, Naoki Fujita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama
International Journal of Clinical Oncology 23 ( 1 ) 134 - 141 2018.2
-
Detecting asymptomatic recurrence after radical nephroureterectomy contributes to better prognosis in patients with upper urinary tract urothelial carcinoma.
Hirotaka Horiguchi, Shingo Hatakeyama, Go Anan, Yuka Kubota, Hirotake Kodama, Masaki Momota, Koichi Kido, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Makoto Sato, Chikara Ohyama
Oncotarget 9 ( 9 ) 8746 - 8755 2018.1
-
Development of high sensitive LacdiNAc-PSA immunoassay system with surface plasmon field- enhanced fluorescence spectroscopy (SPFS)
Kaneko Tomonori, Kaya Takatoshi, Yoneyama Tohru, Tobisawa Yuki, Hatakeyama Shingo, Hashimoto Yasuhiro, Koie Takuya, Ohyama Chikara, Suda Yoshihiko
Japan Journal of Molecular Tumor Marker Research 33 ( 0 ) 19 - 20 2018
-
Anti-tumor growth effect of STIM1 suppression
Han Chong, Yoneyama Tohru, Toyama Yuichi, Yonekura Manabu, Ohyama Chikara, Murakami Manabu
Proceedings for Annual Meeting of The Japanese Pharmacological Society WCP2018 ( 0 ) PO4-6-18 2018
-
Aberrant N-Glycosylation Profile of Serum Immunoglobulins is a Diagnostic Biomarker of Urothelial Carcinomas.
Toshikazu Tanaka, Tohru Yoneyama, Daisuke Noro, Kengo Imanishi, Yuta Kojima, Shingo Hatakeyama, Yuki Tobisawa, Kazuyuki Mori, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Masakazu Tanaka, Shin-Ichiro Nishimura, Shizuka Kurauchi, Ippei Takahashi, Chikara Ohyama
International journal of molecular sciences 18 ( 12 ) 2017.12
-
Aberrant N-Glycosylation Profile of Serum Immunoglobulins is a Diagnostic Biomarker of Urothelial Carcinomas.
Toshikazu Tanaka, Tohru Yoneyama, Daisuke Noro, Kengo Imanishi, Yuta Kojima, Shingo Hatakeyama, Yuki Tobisawa, Kazuyuki Mori, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Masakazu Tanaka, Shin-Ichiro Nishimura, Shizuka Kurauchi, Ippei Takahashi, Chikara Ohyama
International journal of molecular sciences 18 ( 12 ) 2017.12
-
Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution.
Naoki Fujita, Takuya Koie, Chikara Ohyama, Yoshimi Tanaka, Osamu Soma, Teppei Matsumoto, Hayato Yamamoto, Atsushi Imai, Yuki Tobisawa, Tohru Yoneyama, Shingo Hatakeyama, Yasuhiro Hashimoto
International journal of clinical oncology 22 ( 6 ) 1087 - 1093 2017.12
-
Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution
Naoki Fujita, Takuya Koie, Chikara Ohyama, Yoshimi Tanaka, Osamu Soma, Teppei Matsumoto, Hayato Yamamoto, Atsushi Imai, Yuki Tobisawa, Tohru Yoneyama, Shingo Hatakeyama, Yasuhiro Hashimoto
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY 22 ( 6 ) 1087 - 1093 2017.12
-
Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: a multicenter study.
Yuka Kubota, Shingo Hatakeyama, Toshikazu Tanaka, Naoki Fujita, Hiromichi Iwamura, Jotaro Mikami, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Atsushi Sasaki, Toshiaki Kawaguchi, Chikara Ohyama
Oncotarget 8 ( 60 ) 101500 - 101508 2017.11
-
Significance of preoperative butyrylcholinesterase level as an independent predictor of survival in patients with upper urinary tract urothelial carcinoma treated with nephroureterectomy
Daisuke Noro, Takuya Koie, Yasuhiro Hashimoto, Toshikazu Tanaka, Chikara Ohyama, Yuki Tobisawa, Tohru Yoneyama, Atsushi Imai, Shingo Hatakeyama, Hayato Yamamoto, Masato Kitayama, Kazuyoshi Hirota
Japanese Journal of Clinical Oncology 48 ( 2 ) 184 - 189 2017.11
-
Incidental prostate cancer in patients with muscle-invasive bladder cancer who underwent radical cystoprostatectomy.
Toshikazu Tanaka, Takuya Koie, Chikara Ohyama, Yasuhiro Hashimoto, Atsushi Imai, Yuki Tobisawa, Shingo Hatakeyama, Hayato Yamamoto, Tohru Yoneyama, Hirotaka Horiguchi, Hirotake Kodama, Takahiro Yoneyama
Japanese journal of clinical oncology 47 ( 11 ) 1078 - 1082 2017.11